Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

Enrollment Performance

Analytics

No phase data available

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT03967639Unknown

Seasonal Trends of Respiratory Morbidity in Diabetic Patients

Role: collaborator

NCT03816280Unknown

Cerebrovascular Effects of the Use of Alpha-stat or pH-stat Management of Cardiopulmonary Bypass

Role: collaborator

NCT03768973Unknown

Pulmonary Effects of Diabetes Mellitus

Role: collaborator

NCT03668301Completed

Cerebral-tissue Oxygen Balance Affected by Diabetes Mellitus

Role: collaborator

All 4 trials loaded